Fermenta Biotech is undertaking a planned partial shutdown of its manufacturing facility at Dahej to carry out capacity increasing measures for Vitamin D3 crystals with effect from October 5, 2021 for an estimated period of 15 days, until October 20, 2021.
Following the previous shutdown in April 2019, which was successfully completed to increase capacity of Vitamin D3 intermediates, the current shutdown is being taken for increasing Vitamin D3 crystals' capacity. Post completion, the company’s production capacity of Vitamin D3 crystals will increase by around 25%. This initiative is part of company’s capacity enhancement strategy to meet the expected increase in peak demand for Vitamin D3 crystals under the current circumstances.
Fermenta Biotech (formerly known as DIL) is engaged in the business of research support services through their subsidiary Research Support International Ltd. (RSIL), manufacture and marketing of enzymes and chemicals through their subsidiary Fermenta Biotech (FBL).
